69 related articles for article (PubMed ID: 8925998)
1. [Gene K-ras mutation in cells of endometrial adenocarcinoma in women].
Semczuk A; Wojcierowski J; Kitlińska J; Kotarski J; Rózańska K
Ginekol Pol; 1996 May; 67(5):259-63. PubMed ID: 8925998
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
3. Frequent occurrence of c-Ki-ras gene mutations in well differentiated endometrial adenocarcinoma showing infiltrative local growth with fibrosing stromal response.
Tsuda H; Jiko K; Yajima M; Yamada T; Tanemura K; Tsunematsu R; Ohmi K; Sonoda T; Hirohashi S
Int J Gynecol Pathol; 1995 Jul; 14(3):255-9. PubMed ID: 8600078
[TBL] [Abstract][Full Text] [Related]
4. Detection of K-ras mutations in cancerous lesions of human endometrium.
Semczuk A; Berbéc H; Kostuch M; Kotarski J; Wojcierowski J
Eur J Gynaecol Oncol; 1997; 18(1):80-3. PubMed ID: 9061333
[TBL] [Abstract][Full Text] [Related]
5. Studies on ras oncogene activation in endometrial carcinoma.
Fujimoto I; Shimizu Y; Hirai Y; Chen JT; Teshima H; Hasumi K; Masubuchi K; Takahashi M
Gynecol Oncol; 1993 Feb; 48(2):196-202. PubMed ID: 8428691
[TBL] [Abstract][Full Text] [Related]
6. K-ras exon 2 point mutations in human endometrial cancer.
Semczuk A; Schneider-Stock R; Berbec H; Marzec B; Jakowicki JA; Roessner A
Cancer Lett; 2001 Mar; 164(2):207-12. PubMed ID: 11179836
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer.
Esteller M; García A; Martínez-Palones JM; Xercavins J; Reventós J
Eur J Cancer; 1997 Sep; 33(10):1572-7. PubMed ID: 9389917
[TBL] [Abstract][Full Text] [Related]
8. ras gene mutations in human endometrial carcinoma.
Varras MN; Koffa M; Koumantakis E; Ergazaki M; Protopapa E; Michalas S; Spandidos DA
Oncology; 1996; 53(6):505-10. PubMed ID: 8960147
[TBL] [Abstract][Full Text] [Related]
9. K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis.
Mutter GL; Wada H; Faquin WC; Enomoto T
Mol Pathol; 1999 Oct; 52(5):257-62. PubMed ID: 10748874
[TBL] [Abstract][Full Text] [Related]
10. Identification of p53 mutations in endometrial adenocarcinoma by polymerase chain reaction-single-strand conformation polymorphism.
Wachtel SS; Wachtel G; Shulman LP; Phillips O; Miller B; Photopulos G
J Soc Gynecol Investig; 1994; 1(3):234-7. PubMed ID: 9419777
[TBL] [Abstract][Full Text] [Related]
11. K-ras mutations in endometrial carcinomas with microsatellite instability.
Lagarda H; Catasus L; Arguelles R; Matias-Guiu X; Prat J
J Pathol; 2001 Feb; 193(2):193-9. PubMed ID: 11180166
[TBL] [Abstract][Full Text] [Related]
12. [Detection of K-ras oncogene mutations in human lung cancer by PCR-SSCP-DNA direct sequencing].
Fang Q; Li X; Li J; Liang S
Wei Sheng Yan Jiu; 1998 Jan; 27(1):6-8. PubMed ID: 10682630
[TBL] [Abstract][Full Text] [Related]
13. Rare occurrence of p53 and ras gene mutations in preneoplastic and neoplastic mouse endometrial lesions induced by N-methyl-N-nitrosourea and 17 beta-estradiol.
Murase T; Niwa K; Morishita S; Itoh N; Mori H; Tanaka T; Tamaya T
Cancer Lett; 1995 Jun; 92(2):223-7. PubMed ID: 7600534
[TBL] [Abstract][Full Text] [Related]
14. Clonal origin of multiple lung cancers: K-ras and p53 mutations determined by nonradioisotopic single-strand conformation polymorphism analysis.
Lau DH; Yang B; Hu R; Benfield JR
Diagn Mol Pathol; 1997 Aug; 6(4):179-84. PubMed ID: 9360838
[TBL] [Abstract][Full Text] [Related]
15. Mutations and amplification of oncogenes in endometrial cancer.
Niederacher D; An HX; Cho YJ; Hantschmann P; Bender HG; Beckmann MW
Oncology; 1999; 56(1):59-65. PubMed ID: 9885379
[TBL] [Abstract][Full Text] [Related]
16. Detection of clonality and genetic alterations in endometrial pipelle biopsy and its surgical specimen counterpart.
Esteller M; García A; Martínez-Palones JM; Xercavins J; Reventós J
Lab Invest; 1997 Jan; 76(1):109-16. PubMed ID: 9010454
[TBL] [Abstract][Full Text] [Related]
17. Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis.
Alexander-Sefre F; Salvesen HB; Ryan A; Singh N; Akslen LA; MacDonald N; Wilbanks G; Jacobs IJ
Gynecol Oncol; 2003 Oct; 91(1):218-25. PubMed ID: 14529685
[TBL] [Abstract][Full Text] [Related]
18. Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma.
Duggan BD; Felix JC; Muderspach LI; Tsao JL; Shibata DK
Cancer Res; 1994 Mar; 54(6):1604-7. PubMed ID: 8137266
[TBL] [Abstract][Full Text] [Related]
19. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
20. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
